COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Discovery Solutions (PDS)

28 Sep 2021

Piramal offers early stage drug discovery services to pharmaceutical, biotech and academic institutions from its 10,000 m² greenfield campus located in a Special Economic Zone (SEZ). This is a government sponsored industrial park with specialized infrastructure to encourage export and industrialization. Our modern and advanced facility hosts 28 lab units (12 fume-hood reconfigurable modules), a write-up area and research campus that accommodate over 400 scientists.

High Potency API Needs

04 Dec 2017

Piramal Pharma Solutions now offers High Potency API (HPAPI) services following its acquisition of Ash Stevens, a leader in HPAPI development and cGMP manufacture with over five decades of experience.